HALO logo
halo search icon
Sutro Biopharma, Inc.
Sutro Biopharma, Inc.
STRO · NAS

Sutro Biopharma, Inc.

US$31.13

Price Arrow-0.54 (-1.705%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusBig CandleHALO AllHALO Capital EfficiencyHALO Earnings MomentumHALO GrowthHALO Momentum+2
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Sutro Biopharma, Inc. Overview

STRO Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Strong

Balance Sheet

Neutral

About STRO

icon

Telephone

1.650.881.6500

icon

Address

111 Oyster Point Boulevard, South San Francisco, CA 94080

Description

Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics. The company was founded by James R. Swartz and Sutanto Widjaja on April 21, 2003 and is headquartered in South San Francisco, CA.

STRO Price Chart

Key Stats

Market Cap

US$524.79M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 6.74 - 43.85

Trade Value (12mth)

US$601,958.00

1 week

-18.73%

1 month

-7.8%

YTD

188.96%

1 year

277.79%

All time high

283.00

Key Fundamentals

EPS 3 yr Growth

-4.30%

EBITDA Margin

-95.30%

Operating Cashflow

-$177m

Free Cash Flow Return

-105.50%

ROIC

-113.70%

Interest Coverage

-2.60

Quick Ratio

2.00

Other Data

Shares Outstanding (Fully Diluted)

13m

HALO Sector

Healthcare

Next Company Report Date

29-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

STRO Announcements

Latest Announcements

DateAnnouncements
15 May 26
15 May 26
15 May 26
15 May 26
15 May 26

STRO Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-17.75-29.61-22.49locklocklock
EPS (Fully Diluted)
$locklocklocklock-17.75-29.61-22.49locklocklock
Growth
%locklocklocklock24.4-66.824locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Sutro Biopharma, Inc. (STRO:NAS)?
Halo FAQ
The current share price of Sutro Biopharma, Inc. (STRO:NAS) is USD$31.13.
What is the 52-week high share price for Sutro Biopharma, Inc. (STRO:NAS)?
Halo FAQ
The 52-week high share price for Sutro Biopharma, Inc. (STRO:NAS) is USD$43.85.
What is the 52-week low share price for Sutro Biopharma, Inc. (STRO:NAS)?
Halo FAQ
The 52-week low share price for Sutro Biopharma, Inc. (STRO:NAS) is USD$6.74.
What is the dividend yield for Sutro Biopharma, Inc. (STRO:NAS)?
Halo FAQ
Sutro Biopharma, Inc. (STRO:NAS) does not pay a dividend.
What was Sutro Biopharma, Inc. (STRO:NAS) last dividend payment?
Halo FAQ
Sutro Biopharma, Inc. (STRO:NAS) does not pay a dividend.
What is the franking level for Sutro Biopharma, Inc. (STRO:NAS)?
Halo FAQ
Sutro Biopharma, Inc. (STRO:NAS) has a franking level of 0.00%.
In which sector is Sutro Biopharma, Inc. (STRO:NAS) classified?
Halo FAQ
Sutro Biopharma, Inc. (STRO:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.